Literature DB >> 18441154

The cell biology of bone metabolism.

H K Datta1, W F Ng, J A Walker, S P Tuck, S S Varanasi.   

Abstract

Contrary to the commonly held misconception, bone is a relatively dynamic organ that undergoes significant turnover as compared to other organs in the body. This review details how complex intercellular signalling, between the osteoprogenitor cells and mature osteoblasts, osteocytes and osteoclasts, regulates and balances activities of bone cells during remodelling and growth. Both systemic, as well as local autocrine and paracrine factors are discussed. A number of recent important advances in cell biology of bone have led to a new paradigm in understanding of the subject. In this regard, the interaction between the immune system and bone cells is of particular interest, leading to the emergence of a new discipline termed osteoimmunology. The role of lymphocytes and a number of key cytokines in the regulation of osteoclastogenesis and osteoblast function is critically examined. The intracellular signalling regulating key cellular pathways involved in cell differentiation and activity are outlined. The emerging evidence of osteocytes as mechanosensors as well as regulators of mineralisation is discussed.

Mesh:

Year:  2008        PMID: 18441154     DOI: 10.1136/jcp.2007.048868

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  119 in total

1.  Spontaneous and induced osteoclastogenic behaviour of human peripheral blood mononuclear cells and their CD14(+) and CD14(-) cell fractions.

Authors:  J Costa-Rodrigues; A Fernandes; M H Fernandes
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

Review 2.  Psychological stress and aging: role of glucocorticoids (GCs).

Authors:  K M Mehedi Hasan; Md Shaifur Rahman; K M T Arif; Mahbub E Sobhani
Journal:  Age (Dordr)       Date:  2011-10-05

3.  Adenosine A2A receptor activation prevents wear particle-induced osteolysis.

Authors:  Aránzazu Mediero; Sally R Frenkel; Tuere Wilder; Wenjie He; Amitabha Mazumder; Bruce N Cronstein
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

4.  Successes achieved and challenges ahead in translating biomarkers into clinical applications.

Authors:  Greg Tesch; Shashi Amur; John T Schousboe; Jeffrey N Siegel; Lawrence J Lesko; Jane P F Bai
Journal:  AAPS J       Date:  2010-03-16       Impact factor: 4.009

Review 5.  The molecular mechanism behind bone remodelling: a review.

Authors:  Peter Proff; Piero Römer
Journal:  Clin Oral Investig       Date:  2009-03-25       Impact factor: 3.573

6.  Ascorbate-induced osteoblast differentiation recruits distinct MMP-inhibitors: RECK and TIMP-2.

Authors:  Willian F Zambuzzi; Claudia L Yano; Alexandre D M Cavagis; Maikel P Peppelenbosch; José Mauro Granjeiro; Carmen V Ferreira
Journal:  Mol Cell Biochem       Date:  2008-11-07       Impact factor: 3.396

7.  Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.

Authors:  T N Poly; M M Islam; H-C Yang; C C Wu; Y-C J Li
Journal:  Osteoporos Int       Date:  2018-12-12       Impact factor: 4.507

Review 8.  Systems analysis of bone.

Authors:  Karl J Jepsen
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

9.  Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.

Authors:  Nan Su; Qidi Sun; Can Li; Xiumin Lu; Huabing Qi; Siyu Chen; Jing Yang; Xiaolan Du; Ling Zhao; Qifen He; Min Jin; Yue Shen; Di Chen; Lin Chen
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

10.  Pathophysiology of age-related diseases.

Authors:  Giuseppina Campisi; Martina Chiappelli; Massimo De Martinis; Vito Franco; Lia Ginaldi; Rosario Guiglia; Federico Licastro; Domenico Lio
Journal:  Immun Ageing       Date:  2009-09-08       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.